Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study

Purpose: To evaluate the retinal vessel density (VD) with optical coherence tomography angiography (OCTA) in asymptomatic patients affected by Waldenström macroglobulinemia (WM) without hyperviscosity syndrome (HVS) and to highlight the presence of microvascular damage in theese clinically asymptoma...

Full description

Bibliographic Details
Published in:	Photodiagnosis and Photodynamic Therapy
Main Authors:	Gilda Cennamo, Michele Rinaldi, Alessandro Severino, Laura De Fazio, Emanuele Malvone, Vincenzo Martinelli, Ciro Costagliola
Format:	Article
Language:	English
Published:	Elsevier 2024-08-01
Subjects:	OCTA Waldenström macroglobulinemia Hyperviscosity syndrome Retinal vessel density
Online Access:	http://www.sciencedirect.com/science/article/pii/S1572100024003016

Similar Items

CORRIGENDUM: Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Gilda Cennamo, et al.
Published: (2024-12-01)

Blood is Always Thicker than Water – A Case of Renal Involvement in Waldenstrom’s Macroglobulinemia
by: Mohammed Fahad Khan, et al.
Published: (2023-01-01)

Bilateral central retinal vein occlusion as an initial presentation of Waldenström macroglobulinemia: a case report
by: Suraj Shrestha, et al.
Published: (2023-02-01)

Unusual presentation of Waldenstrom macroglobulinemia
by: Chih-Yu Chang, et al.
Published: (2018-03-01)

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
by: Wei Zhou, et al.
Published: (2012-04-01)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
by: Nurhilal Büyükkurt, et al.
Published: (2023-06-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

Mismatches in optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Sunny Chi Lik Au
Published: (2024-12-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
by: Rana Rafiei, et al.
Published: (2020-05-01)

Severe nephritis as initial sign of Waldenström’s macroglobulinemia
by: Thomas Knoop, et al.
Published: (2019-12-01)

Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
by: Xiaowei Xu, et al.
Published: (2013-12-01)

Macroglobulinemia de Waldenström con transformación a Linfoma del manto
by: M. Martínez Gabarrón, et al.
Published: (2013-06-01)

Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström’s macroglobulinemia
by: Omar Abdulfattah, et al.
Published: (2018-03-01)

Diagnóstico presuntivo de la macroglobulinemia de Waldenström Presumptive diagnosis of the macroglobulinemia of Waldenström
by: Ana Dolores Izquierdo Calzado
Published: (2012-04-01)

A rare clinical presentation of Waldenström Macroglobulinemia mimicking lung cancer
by: Michael RT. Laursen, et al.
Published: (2022-01-01)

Mixed cryoglobulinemia; a rare presentation of Waldenström macroglobulinemia
by: Catarina Isabel Ribeiro, et al.
Published: (2022-07-01)

Waldenstrom's macroglobulinemia: An unusual cause of nonhealing leg ulcers
by: Navjyot Kaur, et al.
Published: (2017-01-01)

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
by: Wanlu Ma, et al.
Published: (2021-02-01)

A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis
by: Shinta Oktya Wardhani, et al.
Published: (2017-05-01)

A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis
by: Shinta Oktya Wardhani, et al.
Published: (2017-05-01)

Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
by: Jang Ho Cho, et al.
Published: (2021-05-01)

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
by: Rayan Kaedbey, et al.
Published: (2022-09-01)

Waldenström macroglobulinemia: A clinicopathological profile and review of six cases
by: Priyanka Samal, et al.
Published: (2020-01-01)

Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
by: Richard Lemal, et al.
Published: (2022-05-01)

Acute cryoglobulinemic vasculitis following rituximab infusion for waldenström macroglobulinemia
by: Zach Thornton, BA, et al.
Published: (2023-05-01)

Acute renal failure in a patient with Waldenström's macroglobulinemia: Case report and literature review.
by: Lena Bercz, et al.
Published: (2025-06-01)

A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib
by: Jorge J. Castillo, et al.
Published: (2022-08-01)

Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma
by: Irmak Akarsu, et al.
Published: (2025-10-01)

Nephrotic Syndrome and Waldenstrom’s Macroglobulinemia: A Case Report
by: Ana Isabel Oliveira, et al.
Published: (2023-06-01)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
by: Abdulkadir Erçalışkan, et al.
Published: (2022-11-01)

Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response
by: Despoina Dimitria Kampitsi, et al.
Published: (2025-04-01)

Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
by: Andrea Aiello, et al.
Published: (2017-01-01)

Waldenström's macroglobulinemia with necrotic extremities: A case with challenging diagnosis
by: Seyyed Mojtaba Nekooghadam, et al.
Published: (2023-09-01)

Pseudovitelliform Subfoveal Deposit in Waldenström’s Macroglobulinemia
by: Aurélie Brolly, et al.
Published: (2012-08-01)

A Rare Disease in the Differential Diagnosis of Chylothorax: Waldenström’s Macroglobulinaemia
by: İstemi Serin, et al.
Published: (2020-11-01)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
by: Obada Ababneh, et al.
Published: (2022-05-01)

Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
by: Papanota AM, et al.
Published: (2019-08-01)

Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States
by: Jorge J Castillo, et al.
Published: (2023-02-01)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024-12-01)